To the Editor

Peter Radermacher, Enrico Calzia, Oscar McCook, Ulrich Wachter^{1

2}, Csaba Szabo^{3

4}

Affiliations

¹ Institute for Anesthesiological Pathophysiology and Process Engineering, University Hospital.
² Ulm, Germany.
³ Chair of Pharmacology, OMI Department, Section of Science and Medicine, University of Fribourg.
⁴ Fribourg, Switzerland.

Comment

Peter Radermacher et al. Shock. 2021.

. 2021 Jan 1;55(1):138-139.

doi: 10.1097/SHK.0000000000001602.

Peter Radermacher, Enrico Calzia, Oscar McCook, Ulrich Wachter^{1

2}, Csaba Szabo^{3

4}

¹ Institute for Anesthesiological Pathophysiology and Process Engineering, University Hospital.
² Ulm, Germany.
³ Chair of Pharmacology, OMI Department, Section of Science and Medicine, University of Fribourg.
⁴ Fribourg, Switzerland.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

Reply to Radermacher et al. on "Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus".
Renieris G, Katrini K, Giamarellos-Bourboulis EJ. Renieris G, et al. Shock. 2021 Jan 1;55(1):139-140. doi: 10.1097/SHK.0000000000001603. Shock. 2021. PMID: 32590691 Free PMC article. No abstract available.

Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus.
Renieris G, Katrini K, Damoulari C, Akinosoglou K, Psarrakis C, Kyriakopoulou M, Dimopoulos G, Lada M, Koufargyris P, Giamarellos-Bourboulis EJ. Renieris G, et al. Shock. 2020 Nov;54(5):633-637. doi: 10.1097/SHK.0000000000001562. Shock. 2020. PMID: 32433216 Free PMC article.

1. Bazhanov N, Ansar M, Ivanciuc T, Garofalo RP, Casola A. Hydrogen sulfide: a novel player in airway development, pathophysiology of respiratory diseases, and antiviral defenses. Am J Respir Cell Mol Biol 57 (4):403–410, 2017. - PMC - PubMed
1. Renieris G, Katrini K, Damoulari C, Akinosoglou K, Psarrakis C, Kyriakopoulou M, Dimopoulos G, Lada M, Koufargyris P, Giamarellos-Bourboulis EJ. Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 Coronavirus. Shock 54 (5):633–637, 2020. - PMC - PubMed
1. Wintner EA, Deckwerth TL, Langston W, Bengtsson A, Leviten D, Hill P, Insko MA, Dumpit R, VandenEkart E, Toombs CF, et al. A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol 160 (4):941–957, 2010. - PMC - PubMed
1. Simon F, Scheuerle A, Gröger M, Stahl B, Wachter U, Vogt J, Speit G, Hauser B, Möller P, Calzia E, et al. Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury. Shock 35 (2):156–163, 2011. - PubMed
1. Osipov RM, Robich MP, Feng J, Chan V, Clements RT, Deyo RJ, Szabo C, Sellke FW. Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interact Cardiovasc Thorac Surg 10 (4):506–512, 2010. - PubMed